News
Phase 3 data support use of the oral non-peptide small molecule as potential first-line type 2 diabetes treatment, ...
Portugal fails to report mental health data of its incarcerated population to the World Health Organization, reflecting ...
The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...
A study of 13 insulin-dependent ultra-trail runners reveals how extreme racing fosters self-mastery, social support, and ...
Remote ischemic preconditioning does not reduce postoperative myocardial injury among patients undergoing high- or ...
Dr Heather McArthur describes how ASCO 2025 showcased new standards of care in triple-negative and HER2-positive settings.
A study published in Epidemiology in late May demonstrated that fine particulate matter in wildfire smoke represents a danger to human health considerably longer than a couple of days as previously ...
The prevalence of valley fever in 2019 was considerably higher than that reported through national surveillance.
One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 diabetes in whom the benefits outweigh the risks of immunosuppression.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results